https://pubmed.ncbi.nlm.nih.gov/2665354/

Review
Vaccine

. 1989 Apr;7(2):97-101.
doi: 10.1016/0264-410x(89)90043-1.
Anti-fertility vaccines
G P Talwar ¹ , R Raghupathy
Affiliations

• PMID: 2665354
• DOI: 10.1016/0264-410x(89)90043-1

Abstract
Vaccines are under development for the control of fertility in males and females. This review discusses developments in anti-fertility vaccines at the National Institute of Immunology, New Delhi, India. A single injection procedure for the sterilization or castration of male animals depending on the site at which the injection is given, has passed through field testing and is expected to be on the market in the near future. Vaccines inducing antibodies against the human chorionic gonadotropin have gone through phase I trials with satisfactory results. A vaccine producing a consistently bioeffective antibody response against gonadotropin-releasing hormone is ready for phase I/II clinical trials in patients of carcinoma of prostate after due experimentation in animals and toxicology studies. Research to identify sperm antigens for incorporation into second generation vaccines is in progress.
PIP: Anti-fertility vaccine research carried out at the National Institute of Immunology in New Delhi, India is summarized. The vaccines react against follicle stimulating hormone (FSH), luteinizing hormone (LH), and gonadotropin releasing hormone (GnRH). Intratesticular injection of Bacillus Calmette-Guerin (BCG) in moderate concentrations causes the degeneration of the blood-testes barrier, which finally leads to reversible azoospermia and it is suited for use in animals. Anti-hCG (anti-human chorionic gonadotropin) vaccines include beta-hCG linked to tetanus toxoid /TT (beta-hCG-TT) the alpha-subunit of ovine LH associated with beta-hCG and linked to TT or cholera toxin chain b (CHB/alpha-oLH, beta-hCG-TT/CHB/, the mixture of hCG and oLH, and 37 amino acid carboxy-terminal peptide (CTP) of beta-hCG linked to diphtheria toxoid (DT). The principle of anti-hCG vaccine is to induce antibodies which can bind to hCG and render it biologically inactive. The beta-subunit of hCG has proven efficacious in controlling fertility, and similarly 36 amino acid CTP was effective in baboons. The beta-hCG- TT vaccine evoked the production of anti-hCG antibodies in 61 of 63 women tested. The mixture of beta-hCG and beta-ovine LH conjugated to TT or CHB /formulation M/ and beta-hCG annealed to alpha-ovine LH and conjugated to TT or to CHB (formulation A/ produced improved) immunogenicity. Immunization with GnRH resulted in decreased testicular size, drop of testosterone levels, and marked atrophy of the prostate. Anti-GnRH vaccine would be tried in patients of carcinoma of the prostate. LDH-C4, a sperm-specific mitochondrial antigen, produced an antibody response in baboons and reduced fertility in the females. Animal fertility control vaccines will be shortly on the market, but the use of recombinant DNA techniques should also accelerate the development of others.


Similar articles

• Vaccines for control of fertility and hormone dependent cancers.
  Talwar GP, Singh O, Pal R, Chatterjee N. Int J Immunopharmacol. 1992 Apr;14(3):511-4. doi: 10.1016/0192-0561(92)90183-l. PMID: 1618603 Review.
• Enhancement of antigonadotropin response to the beta-subunit of ovine luteinizing hormone by carrier conjugation and combination with the beta-subunit of human chorionic gonadotropin.
  Talwar GP, Singh O, Singh V, Rao DN, Sharma NC, Das C, Rao LV. Fertil Steril. 1986 Jul;46(1):120-6. doi: 10.1016/s0015-0282(16)49469-0. PMID: 2424791
• Anti-LHRH and anti-pituitary gonadotropin vaccines: their development and clinical applications.
  Thau R. Scand J Immunol Suppl. 1992;11:127-30. doi: 10.1111/j.1365-3083.1992.tb01635.x. PMID: 1514027
• Contraception.
  Jones WR. Baillieres Clin Obstet Gynaecol. 1992 Sep;6(3):629-40. doi: 10.1016/s0950-3552(05)80014-8. PMID: 1446424 Review.
• Antibody response and characteristics of antibodies in women immunized with three contraceptive vaccines inducing antibodies against human chorionic gonadotropin.
  Singh O, Rao LV, Gaur A, Sharma NC, Alam A, Talwar GP. Fertil Steril. 1989 Nov;52(5):739-44. PMID: 2806615

See all similar articles

 Relevance of immuno-contraceptive vaccines for population control. I. Hormonal immunocontraception
S K Gupta  ¹ , P T Koothan
Affiliations

• PMID: 2126920

Abstract
Human chorionic gonadotropin--subunit beta (beta-hCG) has been so far most extensively studied antigen for immuno-contraceptive properties. Studies of vaccination of non-human primates has been so far controversially reported since some antisera obtained from baboons immunized with beta-hCG had shown cross-reactivity to other tissues. Despite these problems and concerns about the complete safety of this first generation vaccine, a decision has been made to proceed with a limited clinical trials with this vaccine. Results from these trials are encouraging and indicate that contraceptive antibody titers can be achieved with permissible adjuvants. Neutralization of LH and/or FSH by circulating antibodies may impede their action and interfere with the maturation of gametes. Gonadotropin releasing hormone can be also a suitable target for immunological attack.
PIP: The human reproductive process entails numerous possible sites for immunological intervention aimed at controlling fertility. Currently under investigation are a vaccine based on gonadotropin releasing hormone (GnRH) interception, regulation of male fertility by immunointerception of follicle-stimulating hormone (FSH), vaccines based on the neutralization of human chorionic gonadotropin (hCG), and anti-hCG immunization. In Phase I clinical trials, passive transfer of anti-GnRH antibody has produced short-term infertility; long-term infertility has been achieved through active immunization against the decapeptide. In terms of FSH, the research has failed to demonstrate how long-term neutralization brings about male infertility. Before immunization against FSh is considered further as a means of immunocontraception, further studies are needed on the required levels of physiological FSH and testosterone for normal testicular functions to be maintained. 4 other Phase I clinical trials in this area involve vaccines based on the beta subunit of hCG or its fragment. Preliminary results from these trials suggest that contraceptive antibody titers can be obtained with permissible adjuvants, especially tetanus toxoid.
Similar articles

• How far from a hormone-based contraceptive vaccine?
  Delves PJ. J Reprod Immunol. 2004 Jun;62(1-2):69-78. doi: 10.1016/j.jri.2003.08.003. PMID: 15288183 Review.
• Anti-LHRH and anti-pituitary gonadotropin vaccines: their development and clinical applications.
  Thau R. Scand J Immunol Suppl. 1992;11:127-30. doi: 10.1111/j.1365-3083.1992.tb01635.x. PMID: 1514027
• Vaccines for control of fertility.
  Talwar GP, Singh O, Pal R, Chatterjee N, Suri AK, Shaha C. Indian J Exp Biol. 1992 Nov;30(11):947-50. PMID: 1293038 Review.
• Vaccines for control of fertility and hormone dependent cancers.
  Talwar GP, Singh O, Pal R, Chatterjee N. Int J Immunopharmacol. 1992 Apr;14(3):511-4. doi: 10.1016/0192-0561(92)90183-l. PMID: 1618603 Review.
• Development of immunological methods of fertility regulation.
  Spieler J. Bull World Health Organ. 1987;65(6):779-83. PMID: 3124969 Free PMC article.

See all similar articles
Cited by 1 article

• The preparation and application of N-terminal 57 amino acid protein of the follicle-stimulating hormone receptor as a candidate male contraceptive vaccine.
  Xu C, Li YC, Yang H, Long Y, Chen MJ, Qin YF, Xia YK, Song L, Gu AH, Wang XR. Asian J Androl. 2014 Jul-Aug;16(4):623-30. doi: 10.4103/1008-682X.125910. PMID: 24713829 Free PMC article.